CORD-19:85d7f47649ef43ff11b8d5196c98e4fdacd0f905 / 34937-35112 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T212","span":{"begin":0,"end":175},"obj":"Sentence"},{"id":"TextSentencer_T212","span":{"begin":0,"end":175},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Additionally, in spike-treated mice, ANG II peptide levels were increased and the worsened ARDS symptoms could be partially reversed by AT 1 receptor blocker treatment [27 ] ."}

{"project":"Epistemic_Statements","denotations":[{"id":"T66","span":{"begin":0,"end":175},"obj":"Epistemic_statement"}],"text":"Additionally, in spike-treated mice, ANG II peptide levels were increased and the worsened ARDS symptoms could be partially reversed by AT 1 receptor blocker treatment [27 ] ."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T212","span":{"begin":0,"end":175},"obj":"Sentence"}],"text":"Additionally, in spike-treated mice, ANG II peptide levels were increased and the worsened ARDS symptoms could be partially reversed by AT 1 receptor blocker treatment [27 ] ."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T431","span":{"begin":91,"end":95},"obj":"Disease"},{"id":"T432","span":{"begin":136,"end":138},"obj":"Disease"},{"id":"T64816","span":{"begin":91,"end":95},"obj":"Disease"}],"attributes":[{"id":"A431","pred":"mondo_id","subj":"T431","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A432","pred":"mondo_id","subj":"T432","obj":"http://purl.obolibrary.org/obo/MONDO_0008840"},{"id":"A90179","pred":"mondo_id","subj":"T64816","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"}],"text":"Additionally, in spike-treated mice, ANG II peptide levels were increased and the worsened ARDS symptoms could be partially reversed by AT 1 receptor blocker treatment [27 ] ."}